Inherited Prion Disease A117V Is Not Simply a Proteinopathy but Produces Prions Transmissible to Transgenic Mice Expressing Homologous Prion Protein
Open Access
- 26 September 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 9 (9), e1003643
- https://doi.org/10.1371/journal.ppat.1003643
Abstract
Prions are infectious agents causing fatal neurodegenerative diseases of humans and animals. In humans, these have sporadic, acquired and inherited aetiologies. The inherited prion diseases are caused by one of over 30 coding mutations in the human prion protein (PrP) gene (PRNP) and many of these generate infectious prions as evidenced by their experimental transmissibility by inoculation to laboratory animals. However, some, and in particular an extensively studied type of Gerstmann-Sträussler-Scheinker syndrome (GSS) caused by a PRNP A117V mutation, are thought not to generate infectious prions and instead constitute prion proteinopathies with a quite distinct pathogenetic mechanism. Multiple attempts to transmit A117V GSS have been unsuccessful and typical protease-resistant PrP (PrPSc), pathognomonic of prion disease, is not detected in brain. Pathogenesis is instead attributed to production of an aberrant topological form of PrP, C-terminal transmembrane PrP (CtmPrP). Barriers to transmission of prion strains from one species to another appear to relate to structural compatibility of PrP in host and inoculum and we have therefore produced transgenic mice expressing human 117V PrP. We found that brain tissue from GSS A117V patients did transmit disease to these mice and both the neuropathological features of prion disease and presence of PrPSc was demonstrated in the brains of recipient transgenic mice. This PrPSc rapidly degraded during laboratory analysis, suggesting that the difficulty in its detection in patients with GSS A117V could relate to post-mortem proteolysis. We conclude that GSS A117V is indeed a prion disease although the relative contributions of CtmPrP and prion propagation in neurodegeneration and their pathogenetic interaction remains to be established. Prions are infectious agents causing incurable brain disease in humans and animals. Prion diseases are by definition transmissible, which means that it should be possible to experimentally transfer disease from patient brain tissue to laboratory animals by inoculation. While many forms of prion disease have been shown to be experimentally transmissible, some inherited forms, in particular, Gerstmann-Sträussler-Scheinker syndrome (GSS) associated with the substitution of valine for alanine at amino acid position 117 (GSS A117V) of the human prion protein gene have not. This has led to the suggestion that such syndromes are not true prion diseases and are better designated non-transmissible proteinopathies. Since prions may transmit more efficiently when the host's normal prion protein amino acid sequence matches that of the infecting prion, we generated transgenic mice expressing human prion protein with the same amino acid sequence found in A117V GSS. We found that brain tissue from GSS A117V patients could transmit disease to these mice, producing the typical brain lesions associated with GSS A117V. We therefore conclude that GSS A117V is an authentic prion disease.Keywords
This publication has 53 references indexed in Scilit:
- Levels of the Mahogunin Ring Finger 1 E3 Ubiquitin Ligase Do Not Influence Prion DiseasePLOS ONE, 2013
- Prion propagation and toxicity in vivo occur in two distinct mechanistic phasesNature, 2011
- Functional Depletion of Mahogunin by Cytosolically Exposed Prion Protein Contributes to NeurodegenerationCell, 2009
- Folding kinetics of the human prion protein probed by temperature jumpProceedings of the National Academy of Sciences of the United States of America, 2009
- Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteinsJournal of General Virology, 2009
- Kuru prions and sporadic Creutzfeldt–Jakob disease prions have equivalent transmission properties in transgenic and wild-type miceProceedings of the National Academy of Sciences of the United States of America, 2008
- Accumulation of prion protein in the brain that is not associated with transmissible diseaseProceedings of the National Academy of Sciences of the United States of America, 2007
- Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion proteinBrain, 2006
- Approaches to Therapy of Prion DiseasesAnnual Review of Medicine, 2005
- Novel Proteinaceous Infectious Particles Cause ScrapieScience, 1982